MicroRNA 143-145 deficiency impairs vascular function

MicroRNAs are required for vascular smooth muscle growth, differentiation and function. MiR143-145 modulates cytoskeletal dynamics and acquisition of the contractile phenotype by smooth muscle cells. Lack of this miRNA cluster results in decreased blood pressure and reduced vasocontraction. As all t...

Full description

Bibliographic Details
Main Authors: Norata, Giuseppe, Pinna, C., Zappella, F., Elia, L., Sala, A., Condorelli, G., Catapano, A.
Format: Journal Article
Published: 2012
Online Access:http://hdl.handle.net/20.500.11937/56210
_version_ 1848759814764625920
author Norata, Giuseppe
Pinna, C.
Zappella, F.
Elia, L.
Sala, A.
Condorelli, G.
Catapano, A.
author_facet Norata, Giuseppe
Pinna, C.
Zappella, F.
Elia, L.
Sala, A.
Condorelli, G.
Catapano, A.
author_sort Norata, Giuseppe
building Curtin Institutional Repository
collection Online Access
description MicroRNAs are required for vascular smooth muscle growth, differentiation and function. MiR143-145 modulates cytoskeletal dynamics and acquisition of the contractile phenotype by smooth muscle cells. Lack of this miRNA cluster results in decreased blood pressure and reduced vasocontraction. As all these observations point to a key role for miR143-145 in the vasculature, we investigated whether miR143-145 deficiency is associated with impaired vascular tone. Vasocontraction was assessed in isolated aortic rings from miR143-145 KO and wild type animals incubated with increasing concentrations of phenylephrine (10 -9 M to 10 -5 M) or KCI 0.3M. In both cases, aortic vessel contraction was dramatically reduced in miR143-145 KO animals compared to controls. Next, aortic rings were pre-contracted with phenylephrine (EC60: 10 -7 M) and concentration responses for acetylcholine were obtained. A significantly reduced vasodilation was observed in miR143-145 KO animals compared to controls and similar results were obtained when an exogenous donor of nitric oxide (sodium nitroprusside) was used. Endothelial nitric oxide synthase or guanylate cyclase mRNA expression were not different between the animal groups thus suggesting to investigate the effect of other vasodilators. Isoprenaline mediated vasodilation was significantly reduced in miR143-145 KO animals compared to controls in the absence or in the presence of the guanylate cyclase inhibitor ODQ (10 -4 M), suggesting that also beta adrenergic vasodilation is impaired following miR143-145 deficiency. Finally, the effect of a stable mimetic prostacyclin, namely iloprost, was investigated and again a reduced vasodilation was observed in miR143-145 KO animals. MiR143-145 deficiency is associated not only with altered vasocontraction but also with impaired vasodilation, which probably reflects the impaired VSMC differentiation phenotype reported in miR143-145 KO animals. Copyright © by BIOLIFE, s.a.s.
first_indexed 2025-11-14T10:05:52Z
format Journal Article
id curtin-20.500.11937-56210
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:05:52Z
publishDate 2012
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-562102017-08-24T02:22:49Z MicroRNA 143-145 deficiency impairs vascular function Norata, Giuseppe Pinna, C. Zappella, F. Elia, L. Sala, A. Condorelli, G. Catapano, A. MicroRNAs are required for vascular smooth muscle growth, differentiation and function. MiR143-145 modulates cytoskeletal dynamics and acquisition of the contractile phenotype by smooth muscle cells. Lack of this miRNA cluster results in decreased blood pressure and reduced vasocontraction. As all these observations point to a key role for miR143-145 in the vasculature, we investigated whether miR143-145 deficiency is associated with impaired vascular tone. Vasocontraction was assessed in isolated aortic rings from miR143-145 KO and wild type animals incubated with increasing concentrations of phenylephrine (10 -9 M to 10 -5 M) or KCI 0.3M. In both cases, aortic vessel contraction was dramatically reduced in miR143-145 KO animals compared to controls. Next, aortic rings were pre-contracted with phenylephrine (EC60: 10 -7 M) and concentration responses for acetylcholine were obtained. A significantly reduced vasodilation was observed in miR143-145 KO animals compared to controls and similar results were obtained when an exogenous donor of nitric oxide (sodium nitroprusside) was used. Endothelial nitric oxide synthase or guanylate cyclase mRNA expression were not different between the animal groups thus suggesting to investigate the effect of other vasodilators. Isoprenaline mediated vasodilation was significantly reduced in miR143-145 KO animals compared to controls in the absence or in the presence of the guanylate cyclase inhibitor ODQ (10 -4 M), suggesting that also beta adrenergic vasodilation is impaired following miR143-145 deficiency. Finally, the effect of a stable mimetic prostacyclin, namely iloprost, was investigated and again a reduced vasodilation was observed in miR143-145 KO animals. MiR143-145 deficiency is associated not only with altered vasocontraction but also with impaired vasodilation, which probably reflects the impaired VSMC differentiation phenotype reported in miR143-145 KO animals. Copyright © by BIOLIFE, s.a.s. 2012 Journal Article http://hdl.handle.net/20.500.11937/56210 restricted
spellingShingle Norata, Giuseppe
Pinna, C.
Zappella, F.
Elia, L.
Sala, A.
Condorelli, G.
Catapano, A.
MicroRNA 143-145 deficiency impairs vascular function
title MicroRNA 143-145 deficiency impairs vascular function
title_full MicroRNA 143-145 deficiency impairs vascular function
title_fullStr MicroRNA 143-145 deficiency impairs vascular function
title_full_unstemmed MicroRNA 143-145 deficiency impairs vascular function
title_short MicroRNA 143-145 deficiency impairs vascular function
title_sort microrna 143-145 deficiency impairs vascular function
url http://hdl.handle.net/20.500.11937/56210